OUR PROGRAMS OUR SCIENCE RESOURCE LINKS NEWS ABOUT US  
 
  
  What are ADDLs?
Why are they relevant?
How can they be treated?
Intellectual Property
Acumen Publications
Other Publications
Acumen
Presentations
Acumen Presentations

Acumen Business Overview

Presenatation at NeuroTech 2006

Designing Therapeutics for ADDLs in Alzheimer’s disease
by Susan Catalano, Ph.D.

Discovery of ADDL-Directed Small Molecular Therapeutics for Alzheimer’s disease
by Grant A. Krafft, Ph.D.

 

 

 


Home | Contact Us | Our Programs | Our Science | News | Site Map
Copyright © 2006 Acumen Pharmaceuticals, Inc.